TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds May 23, 1997
TCL Archive OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB October 13, 1989